Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.

Neil M CarletonGuangjing ZhuM Craig MillerChristine DavisPrakash KulkarniRobert W Veltri

Published in: Cancer reports (Hoboken, N.J.) (2020)

The RBM3 biomarker alone is a strong prognostic marker for the prediction of aggressive PCa and biochemical recurrence. Further, RBM3 appears to be down-regulated in aggressive and recurrent tumors.

Keyphrases

prostate cancer
radical prostatectomy
transcription factor
binding protein
small molecule
nucleic acid